SCM
KRTX

Sio Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Sio Capital Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-24,129
Closed -$4.08M – 61
2023
Q3 		$4.08M Buy
+24,129
New +$4.54M 1.26% 24
2020
Q1 		– Sell
-9,588
Closed -$722K – 93
2019
Q4 		$722K Buy
+9,588
New +$420K 0.17% 63

Other funds holding KRTX

Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

Sio Capital Management's KRTX Position: Q4 2023 in Review

Sio Capital Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q4 2023, closing a stake of 24,129 shares — an estimated $4.08M sold.

Sio Capital Management first reported a position in KRTX in Q4 2019 and held it in 2 quarters. The position peaked at $4.08M in Q3 2023. 328 funds tracked by Wall St. Rank hold KRTX as of Q4 2023.

  • Sio Capital Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Sio Capital Management sold 24,129 Karuna Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $4.08M.
  • Sio Capital Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
  • Sio Capital Management's Karuna Therapeutics, Inc. Common Stock position peaked at $4.08M in Q3 2023.
  • 328 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Sio Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.